Načítá se...

Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is an adult lymphoid malignancy with a variable clinical course. There is considerable interest in the identification of new treatments, as most current approaches are not curative. While most patients respond to initial chemotherapy, relapsed disease is often resi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Appl Basic Med Res
Hlavní autoři: Sachdeva, Mamta, Dhingra, Sameer
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318103/
https://ncbi.nlm.nih.gov/pubmed/25664270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.149245
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!